Tonneau, M., Nolin-Lapalme, A., Kazandjian, S., Auclin, E., Panasci, J., Benlaifaoui, M., Ponce, M., Al-Saleh, A., Belkaid, W., Naimi, S., Mihalcioiu, C., Watson, I., Bouin, M., Miller, W., Hudson, M., Wong, M. K., Pezo, R. C., Turcotte, S., Bélanger, K., Jamal, R., Oster, P., Velin, D., Richard, C., Messaoudene, M., Elkrief, A., & Routy, B. (2022). helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors. Oncoimmunology, 11, . http://access.bl.uk/ark:/81055/vdc_100159167951.0x000007